BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 33549703)

  • 1. Combating deleterious phase transitions in neurodegenerative disease.
    Darling AL; Shorter J
    Biochim Biophys Acta Mol Cell Res; 2021 Apr; 1868(5):118984. PubMed ID: 33549703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tau protein liquid-liquid phase separation can initiate tau aggregation.
    Wegmann S; Eftekharzadeh B; Tepper K; Zoltowska KM; Bennett RE; Dujardin S; Laskowski PR; MacKenzie D; Kamath T; Commins C; Vanderburg C; Roe AD; Fan Z; Molliex AM; Hernandez-Vega A; Muller D; Hyman AA; Mandelkow E; Taylor JP; Hyman BT
    EMBO J; 2018 Apr; 37(7):. PubMed ID: 29472250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liquid-Liquid Phase Separation Promotes Protein Aggregation and Its Implications in Ferroptosis in Parkinson's Disease Dementia.
    Li M; Fan Y; Li Q; Wang X; Zhao L; Zhu M
    Oxid Med Cell Longev; 2022; 2022():7165387. PubMed ID: 36246407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liquid-liquid phase transitions and amyloid aggregation in proteins related to cancer and neurodegenerative diseases.
    de Oliveira GAP; Cordeiro Y; Silva JL; Vieira TCRG
    Adv Protein Chem Struct Biol; 2019; 118():289-331. PubMed ID: 31928729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase Separation and Neurodegenerative Diseases: A Disturbance in the Force.
    Zbinden A; Pérez-Berlanga M; De Rossi P; Polymenidou M
    Dev Cell; 2020 Oct; 55(1):45-68. PubMed ID: 33049211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acetylation Disfavors Tau Phase Separation.
    Ferreon JC; Jain A; Choi KJ; Tsoi PS; MacKenzie KR; Jung SY; Ferreon AC
    Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29734651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pathophysiology of neurodegenerative disease: Disturbing the balance between phase separation and irreversible aggregation.
    Webber CJ; Lei SE; Wolozin B
    Prog Mol Biol Transl Sci; 2020; 174():187-223. PubMed ID: 32828466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of Tau Liquid-Liquid Phase Separation In Vitro.
    Boyko S; Surewicz WK
    Methods Mol Biol; 2023; 2551():245-252. PubMed ID: 36310207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of aberrant phase separation in pathological protein aggregation.
    Chakraborty P; Zweckstetter M
    Curr Opin Struct Biol; 2023 Oct; 82():102678. PubMed ID: 37604044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrostatically Driven Complex Coacervation and Amyloid Aggregation of Tau Are Independent Processes with Overlapping Conditions.
    Lin Y; Fichou Y; Zeng Z; Hu NY; Han S
    ACS Chem Neurosci; 2020 Feb; 11(4):615-627. PubMed ID: 31971365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclic dipeptide-based small molecules modulate zinc-mediated liquid-liquid phase separation of tau.
    Ramesh M; Balachandra C; Baruah P; Govindaraju T
    J Pept Sci; 2023 May; 29(5):e3465. PubMed ID: 36471564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beyond aggregation: Pathological phase transitions in neurodegenerative disease.
    Mathieu C; Pappu RV; Taylor JP
    Science; 2020 Oct; 370(6512):56-60. PubMed ID: 33004511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein Aggregation Landscape in Neurodegenerative Diseases: Clinical Relevance and Future Applications.
    Candelise N; Scaricamazza S; Salvatori I; Ferri A; Valle C; Manganelli V; Garofalo T; Sorice M; Misasi R
    Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34199513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant liquid-liquid phase separation and amyloid aggregation of proteins related to neurodegenerative diseases.
    Ahmad A; Uversky VN; Khan RH
    Int J Biol Macromol; 2022 Nov; 220():703-720. PubMed ID: 35998851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA modulates physiological and neuropathological protein phase transitions.
    Mann JR; Donnelly CJ
    Neuron; 2021 Sep; 109(17):2663-2681. PubMed ID: 34297914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tau liquid-liquid phase separation in neurodegenerative diseases.
    Boyko S; Surewicz WK
    Trends Cell Biol; 2022 Jul; 32(7):611-623. PubMed ID: 35181198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liquid-liquid Phase Separation of α-Synuclein: A New Mechanistic Insight for α-Synuclein Aggregation Associated with Parkinson's Disease Pathogenesis.
    Mukherjee S; Sakunthala A; Gadhe L; Poudyal M; Sawner AS; Kadu P; Maji SK
    J Mol Biol; 2023 Jan; 435(1):167713. PubMed ID: 35787838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory mechanisms of tau protein fibrillation under the conditions of liquid-liquid phase separation.
    Boyko S; Surewicz K; Surewicz WK
    Proc Natl Acad Sci U S A; 2020 Dec; 117(50):31882-31890. PubMed ID: 33262278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of liquid-liquid phase separation in aggregation of the TDP-43 low-complexity domain.
    Babinchak WM; Haider R; Dumm BK; Sarkar P; Surewicz K; Choi JK; Surewicz WK
    J Biol Chem; 2019 Apr; 294(16):6306-6317. PubMed ID: 30814253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrostatic modulation of hnRNPA1 low-complexity domain liquid-liquid phase separation and aggregation.
    Tsoi PS; Quan MD; Choi KJ; Dao KM; Ferreon JC; Ferreon ACM
    Protein Sci; 2021 Jul; 30(7):1408-1417. PubMed ID: 33982369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.